535 related articles for article (PubMed ID: 26708992)
1. Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells.
Lopes-Rodrigues V; Di Luca A; Sousa D; Seca H; Meleady P; Henry M; Lima RT; O'Connor R; Vasconcelos MH
Biochim Biophys Acta; 2016 Mar; 1860(3):618-27. PubMed ID: 26708992
[TBL] [Abstract][Full Text] [Related]
2. Identification of the metabolic alterations associated with the multidrug resistant phenotype in cancer and their intercellular transfer mediated by extracellular vesicles.
Lopes-Rodrigues V; Di Luca A; Mleczko J; Meleady P; Henry M; Pesic M; Cabrera D; van Liempd S; Lima RT; O'Connor R; Falcon-Perez JM; Vasconcelos MH
Sci Rep; 2017 Mar; 7():44541. PubMed ID: 28303926
[TBL] [Abstract][Full Text] [Related]
3. Data supporting the shedding of larger extracellular vesicles by multidrug resistant tumour cells.
Lopes-Rodrigues V; Di Luca A; Sousa D; Seca H; Meleady P; Henry M; Lima RT; O'Connor R; Vasconcelos MH
Data Brief; 2016 Mar; 6():1023-7. PubMed ID: 26958634
[TBL] [Abstract][Full Text] [Related]
4. Different Ability of Multidrug-Resistant and -Sensitive Counterpart Cells to Release and Capture Extracellular Vesicles.
Sousa D; Lima RT; Lopes-Rodrigues V; Gonzalez E; Royo F; Xavier CPR; Falcón-Pérez JM; Vasconcelos MH
Cells; 2021 Oct; 10(11):. PubMed ID: 34831110
[TBL] [Abstract][Full Text] [Related]
5. Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells.
Bebawy M; Combes V; Lee E; Jaiswal R; Gong J; Bonhoure A; Grau GE
Leukemia; 2009 Sep; 23(9):1643-9. PubMed ID: 19369960
[TBL] [Abstract][Full Text] [Related]
6. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
7. Deep Sequencing Analysis Reveals Distinctive Non-Coding RNAs When Comparing Tumor Multidrug-Resistant Cells and Extracellular Vesicles with Drug-Sensitive Counterparts.
Sousa D; Matthiesen R; Lima RT; Vasconcelos MH
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947507
[TBL] [Abstract][Full Text] [Related]
8. Proteins Regulating Microvesicle Biogenesis and Multidrug Resistance in Cancer.
Taylor J; Bebawy M
Proteomics; 2019 Jan; 19(1-2):e1800165. PubMed ID: 30520565
[TBL] [Abstract][Full Text] [Related]
9. Highly-purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct.
Xu R; Greening DW; Rai A; Ji H; Simpson RJ
Methods; 2015 Oct; 87():11-25. PubMed ID: 25890246
[TBL] [Abstract][Full Text] [Related]
10. Multimodal transfer of MDR by exosomes in human osteosarcoma.
Torreggiani E; Roncuzzi L; Perut F; Zini N; Baldini N
Int J Oncol; 2016 Jul; 49(1):189-96. PubMed ID: 27176642
[TBL] [Abstract][Full Text] [Related]
11. Extracellular Vesicles in Chemoresistance.
De Rubis G; Bebawy M
Subcell Biochem; 2021; 97():211-245. PubMed ID: 33779919
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles in the Development of Cancer Therapeutics.
Sun H; Burrola S; Wu J; Ding WQ
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32847103
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Vesicles in Lung Disease.
Kubo H
Chest; 2018 Jan; 153(1):210-216. PubMed ID: 28684288
[TBL] [Abstract][Full Text] [Related]
14. Extracellular vesicles in breast cancer drug resistance and their clinical application.
Yu S; Wei Y; Xu Y; Zhang Y; Li J; Zhang J
Tumour Biol; 2016 Mar; 37(3):2849-61. PubMed ID: 26797784
[TBL] [Abstract][Full Text] [Related]
15. Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways.
Lu JF; Luk F; Gong J; Jaiswal R; Grau GE; Bebawy M
Pharmacol Res; 2013 Oct; 76():77-83. PubMed ID: 23917219
[TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles and anti-cancer drug resistance.
Namee NM; O'Driscoll L
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):123-136. PubMed ID: 30003999
[TBL] [Abstract][Full Text] [Related]
17. Cellular communication via microparticles: role in transfer of multidrug resistance in cancer.
Jaiswal R; Raymond Grau GE; Bebawy M
Future Oncol; 2014 Mar; 10(4):655-69. PubMed ID: 24754595
[TBL] [Abstract][Full Text] [Related]
18. Nanoscale flow cytometry to distinguish subpopulations of prostate extracellular vesicles in patient plasma.
Padda RS; Deng FK; Brett SI; Biggs CN; Durfee PN; Brinker CJ; Williams KC; Leong HS
Prostate; 2019 May; 79(6):592-603. PubMed ID: 30680751
[TBL] [Abstract][Full Text] [Related]
19. Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine.
Fais S; O'Driscoll L; Borras FE; Buzas E; Camussi G; Cappello F; Carvalho J; Cordeiro da Silva A; Del Portillo H; El Andaloussi S; Ficko Trček T; Furlan R; Hendrix A; Gursel I; Kralj-Iglic V; Kaeffer B; Kosanovic M; Lekka ME; Lipps G; Logozzi M; Marcilla A; Sammar M; Llorente A; Nazarenko I; Oliveira C; Pocsfalvi G; Rajendran L; Raposo G; Rohde E; Siljander P; van Niel G; Vasconcelos MH; Yáñez-Mó M; Yliperttula ML; Zarovni N; Zavec AB; Giebel B
ACS Nano; 2016 Apr; 10(4):3886-99. PubMed ID: 26978483
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes.
Minciacchi VR; Freeman MR; Di Vizio D
Semin Cell Dev Biol; 2015 Apr; 40():41-51. PubMed ID: 25721812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
